Similar Search Results

Post-neonatal mortality impacts following grants from the Gavi Vaccine Alliance : an econometric analysis from 2000 to 2014

Kolesar, Robert J.; Audibert, Martine - 2017

Persistent link: https://www.econbiz.de/10011730710

Identification of the drivers of and barriers to COVID-19 vaccine intake behavior using a mixed-method design : implications from a developing country

Kordestani, Arash; Oghazi, Pejvak; Izmir, Onur; Oypan, Oguz - In: Journal of innovation & knowledge : JIK 8 (2023) 4, pp. 1-11

Various COVID-19 vaccines are available across the world. However, short phases of clinical trials for emergency use and myriad rumors about and misinformation on vaccines spread through different media sources, induce confusion and trigger vaccine hesitancy behavior. Although clinical trials...

Persistent link: https://www.econbiz.de/10014504895

Regional Vaccine Manufacturing and Development

World Bank - 2023

COVID-19 has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Despite rapid development of a range of COVID-19 vaccines using innovative technologies, access to these vaccines has been a challenge, with manufacturing mostly concentrated in the...

Persistent link: https://www.econbiz.de/10014579804

The political economy of HIV/AIDS in developing countries : TRIPS, public health systems and free access

Coriat, Benjamin (contributor) - 2008

Persistent link: https://www.econbiz.de/10013550998

What impacts do human mobility and vaccination have on trends in COVID-19 infections? : evidence from four developed countries

Masuhara, Hiroaki; Hosoya, Kei - 2022

Persistent link: https://www.econbiz.de/10014434680

Coherence for health : innovation for new medicines for infectious diseases

Harris, Julie (contributor) - 2009

Persistent link: https://www.econbiz.de/10015054455

Product patents and access to innovative medicines in a post-trips-era

Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019

finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood … pharmaceuticals are launched sooner than non-innovative ones, irrespective of the patent regime in the local market. Using a panel …This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …

Persistent link: https://www.econbiz.de/10011992779

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - 2016

. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …

Persistent link: https://www.econbiz.de/10011509446

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - In: World development : the multi-disciplinary … 99 (2017), pp. 15-27

Persistent link: https://www.econbiz.de/10011925529

Accelerating vaccine innovation for emerging infectious diseases via parallel discovery

Barberio, Joseph; Becraft, Jacob; Ben Chaouch, Zied; … - In: Entrepreneurship and innovation policy and the economy … 2 (2023), pp. 9-39

Persistent link: https://www.econbiz.de/10015049952